Page last updated: 2024-08-24

ferric citrate and Kidney Failure, Chronic

ferric citrate has been researched along with Kidney Failure, Chronic in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19901 (4.17)18.7374
1990's0 (0.00)18.2507
2000's2 (8.33)29.6817
2010's20 (83.33)24.3611
2020's1 (4.17)2.80

Authors

AuthorsStudies
Aslam, N; Basdeo, LM; Govani, M; Wadei, HM1
Rascati, K1
Block, GA; Chertow, GM; Fishbane, S; Neylan, JF; Pergola, PE; Uhlig, K1
Block, GA; Block, MS; Chertow, GM; Isakova, T; Mehta, R; Smits, G; Wolf, M1
Akiba, T; Chertow, GM; Fukagawa, M; Hirakata, H; Kumagai, Y; Nakayama, M; Sawada, K; Yokoyama, K1
Chiang, SS; Lee, CT; Peng, YS; Shu, KH; Wu, IW; Wu, MJ; Wu, MS1
Athreya, BP; Blumenthal, SS; Chang, IJ; Chuang, P; Dwyer, JP; Galphin, CM; Greene, T; Kant, KS; Koury, MJ; Lewis, JB; Linfert, DR; Manley, J; Nossuli, AK; Olivero, JJ; Schulman, G; Sika, M; Smith, MT; Whittier, FC; Zeig, S1
Dwyer, JP; Niecestro, R; Rodby, R; Sinsakul, M; Umanath, K1
Thompson, CA1
Dwyer, JP; Jackson, JH; Lewis, JB; Niecestro, R; Rodby, R; Sika, M; Umanath, K1
Blumenthal, SS; Dwyer, JP; Greco, BA; Greene, T; Hiremath, AN; Jalal, DI; Koury, MJ; Lewis, JB; Ma, KN; Manley, J; Negoi, DG; Niecestro, R; Reisin, E; Sika, M; Umanath, K; Umeukeje, EM; Zeig, S1
Abraham, JD; Arfeen, SS; Bowline, IG; Chernin, G; Dwyer, JP; Fadem, SZ; Goral, S; Greene, T; Koury, M; Lewis, JB; Middleton, J; Sika, M; Sinsakul, MV; Umanath, K; Van Buren, PN; Weiner, DE1
Bond, TC; Dwyer, JP; Lewis, J; Niecestro, R; Rodby, RA; Sika, M; Umanath, K1
Iguchi, A; Iino, N; Kazama, JJ; Narita, I; Watanabe, Y; Yamamoto, S; Yoshita, K1
Fishbane, S; Hazzan, AD; Shah, HH1
Vaziri, ND1
Block, GA1
Aguilar, E; Dwyer, JP; Goral, S; Greco, B; Greene, T; Jalal, D; Lewis, JB; McFadden, M; Sika, M; Umanath, K; Yagil, Y1
Connelly, C; Dwyer, JP; Koury, MJ; Lewis, JB; Niecestro, R; Schulman, G; Sika, M; Umanath, K1
Dwyer, J; Greene, T; Korbet, S; Koury, M; Lewis, J; Shapiro, W; Sika, M; Sinsakul, M; Smith, M1
Anger, M; Blumenthal, SS; Chang, IJ; Dwyer, JP; Kaplan, M; Koury, MJ; Lewis, JB; Schulman, G; Sika, M; Smith, M; Zeig, S1
Andrés, E; Ballarín, J; Barceló, P; Bover, J; Ortiz-Herbener, F1
Dhar, SK; Magana, L; Martinez, C; Smith, EC1
Ghosh, AK1

Reviews

5 review(s) available for ferric citrate and Kidney Failure, Chronic

ArticleYear
Ferric citrate spans mineral metabolism and anemia domains in ESRD: a review of efficacy and safety data.
    Expert review of clinical pharmacology, 2014, Volume: 7, Issue:6

    Topics: Anemia; Chelating Agents; Ferric Compounds; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Phosphates; Phosphorus

2014
Ferric Pyrophosphate Citrate: A Novel Iron Replacement Agent in Patients Undergoing Hemodialysis.
    Seminars in nephrology, 2016, Volume: 36, Issue:2

    Topics: Anemia, Iron-Deficiency; Dialysis Solutions; Diphosphates; Ferric Compounds; Hematinics; Humans; Iron; Kidney Failure, Chronic; Renal Dialysis

2016
Safety Issues in Iron Treatment in CKD.
    Seminars in nephrology, 2016, Volume: 36, Issue:2

    Topics: Anemia, Iron-Deficiency; Cardiovascular Diseases; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Disease Progression; Ferric Compounds; Hematinics; Humans; Iron Compounds; Iron Overload; Kidney Failure, Chronic; Oxidative Stress; Reactive Oxygen Species; Renal Dialysis; Renal Insufficiency, Chronic

2016
Ferric Citrate in Patients With Chronic Kidney Disease.
    Seminars in nephrology, 2016, Volume: 36, Issue:2

    Topics: Anemia, Iron-Deficiency; Ferric Compounds; Hematinics; Humans; Kidney Failure, Chronic; Renal Dialysis; Renal Insufficiency, Chronic

2016
[New therapy strategies in secondary hyperparathyroidism on dialysis (I): new concepts, new treatments].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2005, Volume: 25 Suppl 2

    Topics: Algorithms; Bile Acids and Salts; Calcium; Cardiovascular Diseases; Disease Progression; Drug Therapy, Combination; Epoxy Compounds; Female; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Male; Multivariate Analysis; Niacinamide; Phosphate-Binding Proteins; Phosphates; Phosphorus; Polyamines; Polyethylenes; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors; Sevelamer; Time Factors

2005

Trials

12 trial(s) available for ferric citrate and Kidney Failure, Chronic

ArticleYear
Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease.
    PloS one, 2017, Volume: 12, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Female; Ferric Compounds; Humans; Kidney Failure, Chronic; Male; Middle Aged; Placebos

2017
A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD.
    Journal of the American Society of Nephrology : JASN, 2019, Volume: 30, Issue:8

    Topics: Aged; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferritins; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Hemoglobins; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Length of Stay; Male; Middle Aged; Patient Admission; Phosphates; Pilot Projects; Renal Dialysis; Transferrin

2019
A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2014, Volume: 29, Issue:5

    Topics: Adult; Chelating Agents; Female; Ferric Compounds; Humans; Hyperphosphatemia; Japan; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Polyamines; Renal Dialysis; Sevelamer; Young Adult

2014
Effect of oral ferric citrate on serum phosphorus in hemodialysis patients: multicenter, randomized, double-blind, placebo-controlled study.
    Journal of nephrology, 2015, Volume: 28, Issue:1

    Topics: Administration, Oral; Adult; Aged; Chelating Agents; Double-Blind Method; Female; Ferric Compounds; Ferritins; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Renal Dialysis; Transferrin

2015
Ferric citrate controls phosphorus and delivers iron in patients on dialysis.
    Journal of the American Society of Nephrology : JASN, 2015, Volume: 26, Issue:2

    Topics: Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Female; Ferric Compounds; Humans; Hyperphosphatemia; Iron; Israel; Kidney Failure, Chronic; Male; Middle Aged; Outcome Assessment, Health Care; Phosphorus; Renal Dialysis; Treatment Outcome; United States

2015
Phosphorus binding with ferric citrate is associated with fewer hospitalizations and reduced hospitalization costs.
    Expert review of pharmacoeconomics & outcomes research, 2015, Volume: 15, Issue:3

    Topics: Adult; Chelating Agents; Cost Savings; Ferric Compounds; Hospital Costs; Hospitalization; Humans; Kidney Failure, Chronic; Phosphorus; Renal Dialysis

2015
Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.
    Journal of the American Society of Nephrology : JASN, 2015, Volume: 26, Issue:10

    Topics: Administration, Intravenous; Anemia; Drug Therapy, Combination; Female; Ferric Compounds; Hematinics; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged

2015
The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2015, Volume: 66, Issue:3

    Topics: Acetates; Aged; Calcium; Calcium Compounds; Chelating Agents; Female; Ferric Compounds; Humans; Hyperphosphatemia; Inflammation Mediators; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Polyamines; Renal Dialysis; Sevelamer

2015
Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data.
    Drugs in R&D, 2015, Volume: 15, Issue:3

    Topics: Drug Costs; Female; Ferric Compounds; Hematinics; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis

2015
Rationale and study design of a three-period, 58-week trial of ferric citrate as a phosphate binder in patients with ESRD on dialysis.
    Hemodialysis international. International Symposium on Home Hemodialysis, 2013, Volume: 17, Issue:1

    Topics: Adolescent; Adult; Chelating Agents; Female; Ferric Compounds; Humans; Kidney Failure, Chronic; Male; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Young Adult

2013
The safety and tolerability of ferric citrate as a phosphate binder in dialysis patients.
    Nephron. Clinical practice, 2012, Volume: 121, Issue:1-2

    Topics: Adult; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Color; Constipation; Feces; Female; Ferric Compounds; Ferritins; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Renal Dialysis; Surveys and Questionnaires

2012
Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2013, Volume: 61, Issue:5

    Topics: Administration, Oral; Dose-Response Relationship, Drug; Female; Ferric Compounds; Follow-Up Studies; Hematinics; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Prospective Studies; Renal Dialysis; Time Factors; Treatment Outcome

2013

Other Studies

7 other study(ies) available for ferric citrate and Kidney Failure, Chronic

ArticleYear
Can ferric citrate lead to iron overload in peritoneal dialysis patients?
.
    Clinical nephrology, 2020, Volume: 93, Issue:5

    Topics: Aged; Female; Ferric Compounds; Humans; Hyperphosphatemia; Iron Overload; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis

2020
Comment on: "Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode".
    Drugs in R&D, 2017, Volume: 17, Issue:3

    Topics: Ferric Compounds; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Phosphates; Renal Dialysis

2017
Ferric citrate approved as phosphate binder for patients on dialysis.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2014, Nov-01, Volume: 71, Issue:21

    Topics: Diet; Ferric Compounds; Humans; Kidney Failure, Chronic; Phosphates; Renal Dialysis

2014
Administration of Ferric Citrate Hydrate Decreases Circulating FGF23 Levels Independently of Serum Phosphate Levels in Hemodialysis Patients with Iron Deficiency.
    Nephron, 2015, Volume: 131, Issue:3

    Topics: 25-Hydroxyvitamin D 2; Adult; Aged; Anemia, Iron-Deficiency; Bone Diseases; Chelating Agents; Female; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphates; Prospective Studies; Renal Dialysis; Sevelamer; Young Adult

2015
Adherence rates to ferric citrate as compared to active control in patients with end stage kidney disease on dialysis.
    Hemodialysis international. International Symposium on Home Hemodialysis, 2017, Volume: 21, Issue:2

    Topics: Chelating Agents; Female; Ferric Compounds; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis

2017
Iron absorption and utilization in maintenance hemodialysis patients: oral and intravenous routes.
    The Mount Sinai journal of medicine, New York, 1984, Volume: 51, Issue:2

    Topics: Drug Therapy, Combination; Female; Ferric Compounds; Ferrous Compounds; Humans; Intestinal Absorption; Iron; Iron-Dextran Complex; Kidney Failure, Chronic; Male; Renal Dialysis

1984
Efficacy of ferric citrate as a phosphate-binding agent in end-stage renal disease.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002, Volume: 17, Issue:7

    Topics: Ferric Compounds; Humans; Kidney Failure, Chronic; Phosphates; Reproducibility of Results; Research Design

2002